1. Home
  2. EVOK vs NITO Comparison

EVOK vs NITO Comparison

Compare EVOK & NITO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • NITO
  • Stock Information
  • Founded
  • EVOK 2007
  • NITO 2009
  • Country
  • EVOK United States
  • NITO Israel
  • Employees
  • EVOK N/A
  • NITO N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • NITO
  • Sector
  • EVOK Health Care
  • NITO
  • Exchange
  • EVOK Nasdaq
  • NITO NYSE
  • Market Cap
  • EVOK 7.7M
  • NITO 6.6M
  • IPO Year
  • EVOK 2013
  • NITO N/A
  • Fundamental
  • Price
  • EVOK $4.43
  • NITO $0.31
  • Analyst Decision
  • EVOK
  • NITO
  • Analyst Count
  • EVOK 0
  • NITO 0
  • Target Price
  • EVOK N/A
  • NITO N/A
  • AVG Volume (30 Days)
  • EVOK 7.2M
  • NITO 2.3M
  • Earning Date
  • EVOK 08-12-2025
  • NITO 08-13-2025
  • Dividend Yield
  • EVOK N/A
  • NITO N/A
  • EPS Growth
  • EVOK N/A
  • NITO N/A
  • EPS
  • EVOK N/A
  • NITO N/A
  • Revenue
  • EVOK $11,594,083.00
  • NITO $232,000.00
  • Revenue This Year
  • EVOK $57.82
  • NITO N/A
  • Revenue Next Year
  • EVOK $59.12
  • NITO N/A
  • P/E Ratio
  • EVOK N/A
  • NITO N/A
  • Revenue Growth
  • EVOK 89.89
  • NITO 24.74
  • 52 Week Low
  • EVOK $1.94
  • NITO $0.16
  • 52 Week High
  • EVOK $12.32
  • NITO $3.49
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 53.72
  • NITO 62.62
  • Support Level
  • EVOK $4.26
  • NITO $0.25
  • Resistance Level
  • EVOK $4.73
  • NITO $0.37
  • Average True Range (ATR)
  • EVOK 0.73
  • NITO 0.02
  • MACD
  • EVOK -0.07
  • NITO 0.01
  • Stochastic Oscillator
  • EVOK 25.95
  • NITO 58.87

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About NITO N2OFF INC

N2OFF Inc is a pioneering agri-food tech company dedicated to developing sustainable solutions for the plant-based food industry. Operating through two subsidiaries, it delivers integrated solutions for enhanced safety, quality, and sustainability from field to fork. The Company has two reportable segments: Pathogen prevention and prolong shelf life, and the N2O emissions Global warming solutions.

Share on Social Networks: